Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma

Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA
Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma ( Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA )
4 Jun 2023

Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients

Prof Dennis Slamon - UCLA, Los Angeles, USA
Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients ( Prof Dennis Slamon - UCLA, Los Angeles, USA )
3 Jun 2023

Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India
Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )
25 May 2023

Optimising cervical cancer care in Nigeria

Prof Don Dizon - Rhode Island Hospital, Rhode Island, USA
Optimising cervical cancer care in Nigeria ( Prof Don Dizon - Rhode Island Hospital, Rhode Island, USA )
25 May 2023

Decision making in paediatric oncology

Dr Lulu Chirande - Muhimbili National Hospital, Dar es Salaam, Tanzania
Decision making in paediatric oncology ( Dr Lulu Chirande - Muhimbili National Hospital, Dar es Salaam, Tanzania )
18 May 2023

Achieving health equity in cancer care in the Philippines

Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines
Achieving health equity in cancer care in the Philippines ( Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines )
10 May 2023

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours

Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours ( Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK )
10 May 2023

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023

War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients

Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain
War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )
9 May 2023

Collective efforts to combat cancer in Cambodia

Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia
Collective efforts to combat cancer in Cambodia ( Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia )
5 May 2023

Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence

Dr Jeffrey Weber - NYU Langone’s Perlmutter Cancer Center, Newyork, USA
Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence ( Dr Jeffrey Weber - NYU Langone’s Perlmutter Cancer Center, Newyork, USA )
3 May 2023

Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer

Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
2 May 2023